Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Operating ROA
  • ROS
  • Profit Margin
ros-chart

CVS ROS

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for CVS's Return on Sales (ROS) in Q4'25 stands at 2.04%, marking a recovery from the negative territory observed in the prior quarter. This value reflects a modest improvement in profitability margins for the period ending December 31, 2025, amid ongoing operational challenges. Over the timeframe from Q1'23 to Q4'25, CVS's ROS has exhibited a volatile and generally declining trend, fluctuating between a high of 4.13% in Q3'23 and a low of -2.61% in Q3'25, with an overall average around 2.3%. Notable declines occurred in Q1'24 (2.58%) and Q3'24 (0.91%), followed by a sharp drop into negative values in Q3'25, before rebounding in Q4'25; this pattern suggests persistent pressures on margins, potentially from cost increases or competitive dynamics in the healthcare sector, warranting close monitoring for sustained recovery.